Literature DB >> 12698764

Aerobic exercise training for depressive symptom management in adults living with HIV infection.

Judith L Neidig1, Barbara A Smith, Dale E Brashers.   

Abstract

Aerobic exercise training may help prevent or reduce depressive symptoms experienced by persons living with HIV infection. However, the psychological effects of aerobic exercise have not been studied extensively. This study evaluated the effects of an aerobic exercise training program on self-reported symptoms of depression in HIV-infected adults and examined the convergent validity of two widely used depressive symptom scales. Sixty HIV-infected adults participated in a randomized, controlled trial of a supervised 12-week aerobic exercise training program. As compared to study controls, exercise participants showed reductions in depressive symptoms on all indices, and total depressive symptoms scores were highly correlated. Additional study of the psychological effects of aerobic exercise programs in the target population is recommended.

Entities:  

Mesh:

Year:  2003        PMID: 12698764     DOI: 10.1177/1055329002250992

Source DB:  PubMed          Journal:  J Assoc Nurses AIDS Care        ISSN: 1055-3290            Impact factor:   1.354


  25 in total

1.  Impact of Aerobic and Resistance Exercise on the Health of HIV-Infected Persons.

Authors:  Gregory A Hand; G William Lyerly; Jason R Jaggers; Wesley D Dudgeon
Journal:  Am J Lifestyle Med       Date:  2009-11-01

2.  Low Levels of Physical Activity Among Older Persons Living with HIV/AIDS Are Associated with Poor Physical Function.

Authors:  Rachel H Safeek; Katherine S Hall; Felipe Lobelo; Carlos Del Rio; Audrey L Khoury; Tammy Wong; Miriam C Morey; Mehri S McKellar
Journal:  AIDS Res Hum Retroviruses       Date:  2018-09-20       Impact factor: 2.205

3.  Physical Activity is Associated with Better Neurocognitive and Everyday Functioning Among Older Adults with HIV Disease.

Authors:  Pariya L Fazeli; Maria J Marquine; Catherine Dufour; Brook L Henry; Jessica Montoya; Ben Gouaux; Raeanne C Moore; Scott L Letendre; Steven Paul Woods; Igor Grant; Dilip V Jeste; David J Moore
Journal:  AIDS Behav       Date:  2015-08

Review 4.  The benefits of exercise training for quality of life in HIV/AIDS in the post-HAART era.

Authors:  Joseph T Ciccolo; Esbelle M Jowers; John B Bartholomew
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

5.  Physical activity and health outcomes among HIV-infected men who have sex with men: a longitudinal mediational analysis.

Authors:  Aaron J Blashill; Kenneth H Mayer; Heidi Crane; Jessica F Magidson; Chris Grasso; W Christopher Mathews; Michael S Saag; Steven A Safren
Journal:  Ann Behav Med       Date:  2013-10

6.  The antidepressive effects of exercise: a meta-analysis of randomized trials.

Authors:  Chad D Rethorst; Bradley M Wipfli; Daniel M Landers
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

7.  Physical activity levels and perceived benefits and barriers to physical activity in HIV-infected women living in the deep south of the United States.

Authors:  Kristina E Rehm; Deborah Konkle-Parker
Journal:  AIDS Care       Date:  2016-03-29

8.  Stress management interventions for HIV+ adults: a meta-analysis of randomized controlled trials, 1989 to 2006.

Authors:  Lori A J Scott-Sheldon; Seth C Kalichman; Michael P Carey; Robyn L Fielder
Journal:  Health Psychol       Date:  2008-03       Impact factor: 4.267

9.  HIV testing among Deep South residents with serious psychological distress.

Authors:  Larrell L Wilkinson; Lisa Wigfall; Ryan C Lewis; Tasha R Louis-Nance; Neethu Sebastian; Donna L Richter; Wayne A Duffus; Saundra H Glover
Journal:  J Natl Med Assoc       Date:  2012 Nov-Dec       Impact factor: 1.798

10.  Effectiveness of aerobic exercise for adults living with HIV: systematic review and meta-analysis using the Cochrane Collaboration protocol.

Authors:  Kelly K O'Brien; Anne-Marie Tynan; Stephanie A Nixon; Richard H Glazier
Journal:  BMC Infect Dis       Date:  2016-04-26       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.